age-matched healthy control fibroblasts (Coriell Institute for Medical Research)
90
Structured Review
Coriell Institute for Medical Research
age-matched healthy control fibroblasts
Age Matched Healthy Control Fibroblasts, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/age-matched+healthy+control+fibroblasts/age+matched+healthy+control+fibroblasts/pm35675433-333-38-43
Average 90 stars, based on 1 article reviews
Age Matched Healthy Control Fibroblasts, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/age-matched+healthy+control+fibroblasts/age+matched+healthy+control+fibroblasts/pm35675433-333-38-43
Average 90 stars, based on 1 article reviews
age-matched healthy control fibroblasts - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Variant Assay:Article Title: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Article Snippet: Danna Jennings1*†, Sarah Huntwork-Rodriguez1†, Anastasia G. Henry1†, Jennifer C. Sasaki1, René Meisner1, Dolores Diaz1, Hilda Solanoy1, Xiang Wang1, Elvira Negrou1‡, Vitaliy V. Bondar2, Rajarshi Ghosh1, Michael T. Maloney1, Nicholas E. Propson1, Yuda Zhu1, Romeo D. Maciuca1, Laura Harris1, Angela Kay1, Peter LeWitt3, T. Alex King4, Drew Kern5, Aaron Ellenbogen6, Ira Goodman7, Andrew Siderowf8, Jason Aldred9, Omid Omidvar10, Shababa T. Masoud1, Sonnet S. Davis1, Annie Arguello1, Anthony A. Estrada1, Javier de Vicente1, Zachary K. Sweeney11, Giuseppe Astarita12,13§, Marie T. Borin1, Bradley K. Wong1, Harvey Wong14, Hoang Nguyen1, Kimberly Scearce-Levie1, Carole Ho1, Matthew D. Troyer1 Inhibition:Article Title: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Article Snippet: Danna Jennings1*†, Sarah Huntwork-Rodriguez1†, Anastasia G. Henry1†, Jennifer C. Sasaki1, René Meisner1, Dolores Diaz1, Hilda Solanoy1, Xiang Wang1, Elvira Negrou1‡, Vitaliy V. Bondar2, Rajarshi Ghosh1, Michael T. Maloney1, Nicholas E. Propson1, Yuda Zhu1, Romeo D. Maciuca1, Laura Harris1, Angela Kay1, Peter LeWitt3, T. Alex King4, Drew Kern5, Aaron Ellenbogen6, Ira Goodman7, Andrew Siderowf8, Jason Aldred9, Omid Omidvar10, Shababa T. Masoud1, Sonnet S. Davis1, Annie Arguello1, Anthony A. Estrada1, Javier de Vicente1, Zachary K. Sweeney11, Giuseppe Astarita12,13§, Marie T. Borin1, Bradley K. Wong1, Harvey Wong14, Hoang Nguyen1, Kimberly Scearce-Levie1, Carole Ho1, Matthew D. Troyer1 Control:Article Title: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Article Snippet: Danna Jennings1*†, Sarah Huntwork-Rodriguez1†, Anastasia G. Henry1†, Jennifer C. Sasaki1, René Meisner1, Dolores Diaz1, Hilda Solanoy1, Xiang Wang1, Elvira Negrou1‡, Vitaliy V. Bondar2, Rajarshi Ghosh1, Michael T. Maloney1, Nicholas E. Propson1, Yuda Zhu1, Romeo D. Maciuca1, Laura Harris1, Angela Kay1, Peter LeWitt3, T. Alex King4, Drew Kern5, Aaron Ellenbogen6, Ira Goodman7, Andrew Siderowf8, Jason Aldred9, Omid Omidvar10, Shababa T. Masoud1, Sonnet S. Davis1, Annie Arguello1, Anthony A. Estrada1, Javier de Vicente1, Zachary K. Sweeney11, Giuseppe Astarita12,13§, Marie T. Borin1, Bradley K. Wong1, Harvey Wong14, Hoang Nguyen1, Kimberly Scearce-Levie1, Carole Ho1, Matthew D. Troyer1 |